ABSTRACT
Recent Ebola virus disease (EVD) outbreaks have been limited not only to the interactions between humans but also to the complex interplay of the environment, human and socio-economic factors. Changes in human behaviour as a result of fear can also affect disease transmission dynamics. In this paper, a compartmental model is used to study the dynamics of EVD incorporating fear and environmental transmission. We formulate a fear dependent contact rate function to measure the rate of person to person, as well as pathogen to person transmissions. The epidemic threshold and the model equilibria are determined and, their stabilities are analysed. The model is validated by fitting it to data from the 2019 and 2020 EVD outbreaks in the Democratic Republic of Congo. Our results suggest that the fear of death from EVD may reduce the transmission and aid the control of the disease, but it is not sufficient to eradicate the disease. Policymakers need to also implement other control measures such as case finding, media campaigns, Quarantine and increase in the number of beds in the Ebola treatment centers, good laboratory services, safe burials and social mobilisation, to eradicate the disease.
Highlights
Due to its high case fatality rate, EVD undoubtedly instills fear in the inhabitants of any affected community.
We propose an Ebola model with fear, which considers the pathogens in the environment to quantify the effect of fear and environmental transmission on the EVD disease dynamics.
The fear of death from Ebola is proportional to the Ebola disease transmission rate.
At high levels of fear, the number of EVD cases decrease.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Nil
Funding Statement
No funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used was accessed from https://www.who.int/emergencies/diseases/ebola/drc-2019
